In addition to colorectal cancer, FOXK2 has also been shown to act as an oncogene in hepatocellular carcinoma (HCC), in which it has been demonstrated to promote cell migration and proliferation with the involvement of the PI3K/AKT signaling pathway [49]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.